Heart failure with preserved ejection fraction and pulmonary hypertension: focus on phosphodiesterase inhibitors

HIGHLIGHTS

  • who: Artem Ovchinnikov and colleagues from the Named after Academician EIChazov, d Cherepkovskaya St., a, Moscow, Russia Department of Clinical Functional Diagnostics, A.I. Yevdokimov Moscow State University of Medicine and have published the paper: Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors, in the Journal: Pharmaceuticals 2022, 15, 1024. of /2022/
  • what: The patients in this study demonstrated pronounced LV hypertrophy (mean LV mass index was 133 g/m2 ) that was higher than in the RELAX trial and in the study of Liu et_al ( and amp;lt;80 g . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?